Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Faust changes name to Domain Therapeutics

This article was originally published in Scrip

Executive Summary

Faust Pharmaceuticals has changed its name to Domain Therapeutics to reflect its new business model and activities better. The company was previously focused on its G protein-coupled receptors (GCPR) technology to build its own pipeline, but will now give other companies involved in GCPR drug discovery access to this platform. Domain will explore other targets to concentrate on areas outside of central nervous system diseases. Domain hopes to raise funds and sign collaborations for its technology platformand build partnerships for its products.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts